Here are relevant reports on : cell-based-assays-market
-
Aluminum Foam Market by Type (Open-Cell, Closed-Cell), Application (Anti-Intrusion Bars, Heat Exchangers, Sound Absorbers, Filters), End-Use Industry (Automotive, Construction & Infrastructure, Industrial), and Region - Global Forecast to 2027
The aluminum foam market is expected to grow from USD 43 million in 2022 to USD 55 million by 2027, at a CAGR of 4.8% during the forecast period. The key players in the market include ERG Aerospace Corporation (US), CYMAT Technologies Ltd. (Canada), Alantum (South Korea), Liaoning Rontec Advanced Material Technology Co., Ltd. (China), Shanxi Putai Aluminum Foam Manufacturing Co., Ltd. (China), Mayser GmbH & Co. KG (Germany), Aluminum King Co., Ltd (China), and Pohltec Metalfoam GmbH (Germany). These companies have adopted expansions and joint ventures as a part of their strategic development.
- Published: February 2023
- Price: $ 4950
- TOC Available:
-
Cell-free Protein Synthesis Market by Offering (Cell Extract Systems (Prokaryotic, Mammalian, Plant), Kits, Instruments, Services), Workflow, Method (Coupled TX/TL, Transcription, Translation), Application (Protein Purification) - Global Forecast to 2030
The global cell-free protein synthesis market, valued at US$203.9 million in 2024, stood at US$217.2 million in 2025 and is projected to advance at a resilient CAGR of 7.3% from 2024 to 2030, culminating in a forecasted valuation of US$308.9 million by the end of the period. Market growth is driven by increasing demand for biologics, vaccines, and personalized medicine, advancements in CFPS technologies, the need for quick prototyping of complex proteins, and the demand for commercial-scale validation of cell-free protein expression systems.
- Published: October 2025
- Price: $ 4950
- TOC Available:
-
Cell Lysis Market / Fractionation Market by Product (Consumables (Enzymes, Detergent), Instruments (Sonicators)), Cell Type (Mammalian), Application (Protein Purification), End User (Biopharmaceutical & Biotechnology Companies) & Region - Global Forecast to 2026
The global cell lysis market growth is primed to transition from $2.9 billion in 2021 to $4.1 billion by 2026, showcasing a strong CAGR of 7.2%. Growth of the market is driven mainly by increasing government funding for research, the high prevalence of diseases, and a growing focus on personalised medicine.
- Published: March 2021
- Price: $ 4950
- TOC Available:
-
Cell Harvesting Market by Type (Manual, Automated), Application (Biopharmaceutical, Stem Cell Research), End User (Biotechnology, Biopharmaceutical Companies, Research Institute), and Region (North America, Europe, APAC, Row) - Global Forecasts to 2023
The global cell harvesting market is expected to reach USD 324.5 Million by 2023, at a CAGR of 8.7%. Some of the major players operating in the cell harvesting market are PerkinElmer (US), Brandel (US), TOMTEC (US), Cox Scientific (UK), Connectorate (Switzerland), Scinomix (US), ADSTEC (Japan), and Terumo BCT (a part of Terumo Corporation) (Japan).
- Published: March 2018
- Price: $ 4950
- TOC Available:
-
ASEAN Point of Care Diagnostics Market by Product (Infectious Disease (TB, Hepatitis, STDs, HAIs), Glucose, Cardiometabolic, Pregnancy, Coagulation), Technology (Lateral Flow Assays, Biochemistry, MDx), End User (Home Care, Hospitals) - Forecast to 2030
Global ASEAN point of care diagnostics market valued at $1.05B in 2024, reached $1.08B in 2025, and is projected to grow at a robust 4.7% CAGR, hitting $1.36B by 2030. The increasing incidence of chronic conditions, especially diabetes, generates the demand for regular monitoring and early detection, boosting the need for rapid & accurate POC testing solutions
- Published: May 2025
- Price: $ 4950
- TOC Available:
-
ATP Assays Market by Product (Consumables (Reagents, Microplate), Instruments (Luminometer, Spectrophotometer)), Application (Contamination, Disease Testing, Drug Discovery), End User (Hospitals, Pharmaceuticals, F&B, Academics) & Region - Global Forecast to 2028
The global atp assays market, valued at US$0.2 billion in 2021, stood at US$0.3 billion in 2023 and is projected to advance at a resilient CAGR of 7.8% from 2023 to 2028, culminating in a forecasted valuation of US$0.5 billion by the end of the period.The expansion of this market is primarily propelled by the shift from culture-based tests to rapid tests, rising demand for cell-based assays in research, and the rising demand for ATP assays in pharmaceutical companies.
- Published: June 2023
- Price: $ 4950
- TOC Available:
-
Pyrogen Testing Market by Product & Service (Assays, Kits, Reagents, Instruments, Services), Test Type (LAL, Chromogenic, Turbidimetric, Gel Clot, In Vitro, Rabbit), End User (Pharmaceutical, Biotechnology, Medical Device) & Region - Global Forecasts to 2025
The global pyrogen testing market growth is primed to transition from $927 million in 2020 to $1,689 million by 2025, showcasing a strong CAGR of 12.7%. Market drivers include increasing demand for personalized medicine, R&D in pharmaceuticals and biotechnology, rising chronic and infectious diseases, and growing awareness of food safety.
- Published: November 2020
- Price: $ 4950
- TOC Available:
-
Neuroscience Antibodies & Assays Market by Product (Reagent (Media, Sera, Stain, Enzymes, Probe), Instruments), Technology (Immunoassay (Elisa), Molecular Diagnostics), Application (IVD) & End User (Research Institute, Hospital) - Global Forecast to 2023
The global neuroscience antibodies and assays market is expected to reach USD 4.18 Billion by 2023, at a CAGR of 10.2%. Growth in this market is driven by the rising incidence of neurological diseases, increasing investments in neuroscience research, and growth in the pharmaceutical and biotechnology industries. The neuroscience antibodies and assays market is fragmented, with the presence of several large as well as emerging players. Some of the the top players in this market are Thermo Fisher Scientific (US), Abcam (UK), Bio-Rad (US), and Merck KGaA (Germany).
- Published: May 2018
- Price: $ 4950
- TOC Available:
-
Gold Nanoparticles Market by Process (Physical, Chemical, Biological), Application (Imaging, Targeted Drug Delivery, Proton Therapy, In-Vitro Assays, Sensors, Probes, Catalysis), End-Use Industry and Region - Global Forecast to 2029
The gold nanoparticles market is expected to grow from USD 0.50 billion in 2024 to USD 1.11 billion in 2029, at a CAGR of 16.3% during the forecast period. Prominent companies include BBI Solutions (UK), Cytodiagnostics Inc (Canada), Fortis Life Sciences, LLC. (US), Meliorum Technologies, Inc (US), TANAKA PRECIOUS METAL GROUP Co., Ltd. (Japan), Merck KGaA (Germany), Nanopartz, Inc (US), CD Bioparticles (US), Nano Labs (India), Nanocs Inc. (US), NanoHybrids (US), Sona Nanotech (Canada), Sisco Research Laboratories Pvt, Ltd. (India), Nanoprobes, Inc (US), American Elements (US), TORSKAL (France), Abcam Limited (UK), Particular GmbH (Germany), Dongguan Sat Nano Technology Material Co., Ltd (China), Nano Flow (Belgium), Strem Catalog (US), Nanorh (India), SkySpring Nanomaterials (US), Aurion (Netherlands), NNCrystal US Corporation (US), and among others.
- Published: March 2025
- Price: $ 4950
- TOC Available:
-
Genetic Toxicology Testing Market by Product (Assays, Reagents & Consumables, Services), By Application (Healthcare Industry, Food Industry, Cosmetics Industry, Agriculture Industry) & Region - Global Forecast to 2025
The global genetic toxicology testing market growth is primed to transition from $1.2 billion in 2020 to $2.0 billion by 2025, showcasing a strong CAGR of 10.2%. Growth in this market is primarily driven by increased pharmaceutical research activities, opposition to animal testing, and R&D on early toxicity detection.
- Published: December 2020
- Price: $ 4950
- TOC Available:
Records 41 to 50 of 50
